DR JAMES MUECKE MBBS (Hons)
Dr James Muecke graduated with Honours from the University of Adelaide Medical School in 1987. Following his internship at the Royal Adelaide Hospital in 1988, Dr Muecke worked as a Resident Medical Officer at Tumu Tumu Hospital in Kenya. He trained as a general ophthalmologist in Adelaide from 1992 to 1994 and was awarded a Fellowship to work at St. John Ophthalmic Hospital in Jerusalem in 1995. During his year in Jerusalem, he traveled to villages and refugee camps in the West Bank and Gaza Strip to conduct weekly outreach eye clinics. Following subspecialty training in ophthalmic plastic surgery and ocular oncology in England, he returned to Adelaide in 1998 to take up positions as a Visiting Ophthalmologist and Director of the Ocular Oncology Units in the Departments of Ophthalmology at the Royal Adelaide and Women’s and Children’s Hospitals.
Dr Muecke has a strong interest in ophthalmic development and blindness prevention in the developing world. He was the Director of the Vision Myanmar Program (VMP) of the South Australian Institute of Ophthalmology and has been actively involved in surgical teaching, epidemiological studies, public health campaigns, infrastructure development and blindness prevention in Myanmar since 2000. He is an author and co-author of numerous publications generated from studies in Myanmar. He is the author, photographer and publisher of “Visions of Myanmar”, a fund-raising coffee table book that raised over $100,000 for eye care in Myanmar.
Dr Muecke has also been involved in blindness prevention activities in Bangladesh, Bhutan, Cambodia, Indonesia, Laos, Nepal, Sri Lanka and Vietnam. He is the founding chairman of “Sight For All Foundation”, a not-for-profit organization committed to fighting blindness in the developing world (www.sightforall.org).
- Ernst & Young Entrepreneur of the Year (Central Division, Social Category) July 2015
- Finalist Pride of Australia Medal 2014
- President’s Leadership Award for blindness prevention in developing countries – Australian Medical Association, May 2013.
- Rural Health and Wellbeing Award for service to Aboriginal eye health in South Australia, November 2012.
- Member of the Order of Australia for the provision of eye health services to Asian and Australian Aboriginal communities, June 2012.
- Outstanding Service to the Prevention of Blindness Award – Asia Pacific Academy of Ophthalmology, March 2011.
- Finalist, South Australian of the Year, 2010.
Professor Denis Wakefield AO
Prof Wakefield is a clinical immunologist with a long-standing research interest in the pathogenesis of inflammatory eye diseases (IED), such as uveitis, scleritis and pterygia. Significant scientific discoveries have been made in the areas of the role of HLA B27, cytokines, adhesion molecules, chemokines, Toll like receptors and MMPs, in the pathogenesis of IED and pterygia.
Prof Wakefield is the Director of the Laboratory of Ocular Inflammation and the Inflammation Research Unit, Professor of Medicine and Foundation professor of the School of Medical Sciences. in the Faculty of Medicine at UNSW and Director of the Centre for Immunology.
Prof Wakefield has published mostly in relevant high impact journals with over 350 peer-reviewed publications, 20 book chapters. He has published in Stem Cells, Lancet, Diabetes, FASEB J, J Immunol, American J Pathol, Ophthalmology and Invest Ophthalmol Vis Science and has a H-index of 42 (Web of Science).
Prof Wakefield is a foundation member of the International Ocular Inflammation group and serves as an Editor of the Journal produced by this organization. He also serves on the editorial board of BMC Ophthalmology and Ophthalmic Inflammation and Infection and has previously sat of the editorial boards of Internal Medicine Journal and Ocular Immunology and Inflammation. Over the course of his career he has given many invited lectures at international conferences including more than 30 in the last 10 years. He has supervised to completion 20 PhD, 5 MSc, and 3 MD students. His excellence in research student supervision was recognised by UNSW with the award of the Vice Chancellor’s Award for Teaching excellence in 2008.
In 2015 he was awarded an Order of Australia for services to medicine.
Dr David R Hardten MD
Dr. David R. Hardten, a board-certified ophthalmologist and founding partner of Minnesota Eye Consultants, is a prominent leader in the treatment of the cornea, external disease, anterior segment, cataract, refractive and laser surgery – as well as in research and education.
As director for Minnesota Eye Consultants’ Clinical Research Department, Dr. Hardten leads research projects surrounding LASIK Eye Surgery, refractive surgery, complex case management, cataract surgery, natural lens replacement surgery, glaucoma management, corneal transplantation, iris reconstruction, surgical instrumentation and drug therapies.
Dr. Hardten has received numerous awards for his dedication to the eye care industry including the 2011 Casebeer Award for outstanding contribution to the research and development of refractive surgery from the International Society of Refractive Surgery, the 2011 Allina HOPE (Hospital Outstanding Patient Experience) Award, and the 2010 American Academy of Ophthalmology Lifelong Education for the Ophthalmologist Continuing Education Recognition Award.
A native of Overland Park, KS, Dr. Hardten graduated from Shawnee Mission South High School. He attended the University of Kansas undergraduate and medical schools, and was then accepted in the University of Minnesota Department of Ophthalmology residency program. While completing residency training, Dr. Hardten received numerous honors and awards for outstanding achievement. He completed his fellowship training in cornea and external disease at the University of Minnesota and Phillips Eye Institute and received the ARVO/National Eye Institute Fellow Award.
Dr. Hardten entered private practice in 1993 with Drs. Richard L. Lindstrom and Thomas W. Samuelson, also founding partners of Minnesota Eye Consultants. He is an attending ophthalmologist at Phillips Eye Institute in Minneapolis, Minnesota, as well.
In addition to an active clinical and surgical practice, Dr. Hardten has focused on education throughout his career. He is an adjunct associate professor of ophthalmology at the University of Minnesota Department of Ophthalmology and serves as an adjunct professor for the Illinois College of Optometry. Additionally, he is an instructor for VISX/AMO and TLCVision, where he teaches ophthalmologists from around the world to perform LASIK.
Dr. Hardten consults for many major ophthalmologic companies, holds nine U.S. patents for innovations in eye care, and serves on the editorial board for several ophthalmic journals. He is a regular contributor and reviewer for numerous ophthalmic papers and journals.
Dr. Hardten has held leadership positions in many professional organizations, including board director for the International Society of Refractive Surgery and the Contact Lens Association of Ophthalmologists; co-medical director for Laser Vision Centers, Inc.; clinical advisory board for TLCVision; board of directors and program director for the Refractive Surgery Interest Group of the American Academy of Ophthalmology. While serving for the American Academy of Ophthalmology, he received its distinguished achievement award in 1999 and the senior achievement award in 2006 for his countless efforts on behalf of the Academy.
In addition to his active practice in medical and surgical diseases of the cornea and refractive and IOL surgery, Dr. Hardten lectures throughout the world on refractive surgery and research. He has published hundreds of textbook chapters, articles and abstracts on cornea, cataract and refractive surgery.
Dr. Hardten resides in Excelsior, MN, with his wife, Christine, and their two daughters. In his free time, he enjoys golf, tennis and travel.
Dr. Fiona Costello
Dr Fiona Costello is an associate professor, affiliated with the Departments of Clinical Neurosciences and Surgery (Ophthalmology), University of Calgary; Director, Office of Surgical Research, Department of Surgery, University of Calgary; and a Clinician Scientist with the Hotchkiss Brain Institute.
Professor Gerard Sutton
“Professor Sutton holds the Douglas & Lola Douglas Chair in Clinical Ophthalmology & Eye Health and is the Sydney Medical School Foundation Professor of Corneal & Refractive Surgery at Sydney University. Despite the lengthy title he could best be described as an inquisitive surgeon rather than a career academic. He completed his ophthalmic training at Sydney Eye Hospital, before fellowship training in corneal, cataract and refractive surgery at Royal North Shore Hospital, St Thomas Hospital & Moorfields Hospital in London and the Friedrich-Alexander University in Erlangen, Germany. He was awarded his Doctorate of Medicine at Auckland University in 2009.
He currently directs a corneal research team at the Save Sight Institute at Sydney Eye Hospital where he is also the Medical Director of the Lions NSW Eye Bank. He has published over 100 papers and textbook chapters and given over 100 invited lectures locally and internationally.
Gerard has been involved in surgical skill exchange programs in South East Asia for over 15 years. Together with his colleagues, he established the 1st Lions Branch in Myanmar where he currently supervises a Corneal Surgical and Eye Bank program. In 2015 he was appointed Visiting Professor at the University of Medicine, Mandalay.
Career highlights and appointments include; Chief Ophthalmologist Sydney Olympics 2000, Council of Asia Cornea Society 2009, establishment of the 1st degree in Refractive Surgery at Sydney University 2010, International Independent Publishing Award for “The Naked Eye” (co-authored) 2014, International Delphi Panel on Keratoconus 2014, APAO Achievement Award 2015, Lions International Achievement Award 2015, Visiting Professor LV Prasad India 2015, Fellow of the Asia Pacific Academy of Professors of Ophthalmology 2015.
He remains extremely grateful to his many mentors, friends and collaborators understanding that nothing of significance is ever achieved alone.
Prof Keith Martin
Keith Martin was elected as the first Professor of Ophthalmology at the University of Cambridge in 2010. He is Head of Ophthalmology at the University of Cambridge, Deputy Director of the University’s John van Geest Centre for Brain Repair and an Affiliate Principal Investigator at the Wellcome Trust – MRC Cambridge Stem Cell Institute. He is also Academic Lead for Ophthalmology and Lead Clinician for Glaucoma at the Cambridge University Hospitals NHS Foundation Trust. He graduated from the University of Cambridge with a ‘Triple First’ in Medical Sciences and Neuroscience before completing clinical Training at Oxford University Clinical School, Ophthalmology Residency in Cambridge and Clinical and Research Fellowships in Glaucoma at Moorfields Eye Hospital in London and the Wilmer Eye Institute in Baltimore.
Professor Martin established and runs the Glaucoma Research Laboratory at the University of Cambridge, working to develop new treatments for eye disease using stem cells, gene therapy and other techniques. In 2010, Professor Martin won the ARVO Foundation for Eye Research Translational Research Award, an international prize to a researcher from any country under the age of 50 years whose research is judged to have the potential to lead to major breakthroughs in the treatment of eye disease. He was also a winner of the World Glaucoma Association Senior Clinician Scientist Award in 2011.
Clinically, Professor Martin specialises in the medical and surgical management of complex glaucoma in adults and children. He is Basic Science Section Co-Editor of the Journal of Glaucoma and Vice-President and President Elect of the World Glaucoma Association.
Prof. Maarten Mourits
Maarten Mourits finished his medical studies at the University of Amsterdam in 1980. His first medical position was that of a general practitioner in Djoemoe, in the interior of Surinam. After 1,5 years of general surgery not in training, he specialized in ophthalmology with Professor R.A. Crone in Amsterdam. Thereafter, he superspecialized in orbital, lacrimal and eyelid surgery with Professor Leo Koornneef and in Moorfields. He did his PhD in 1990 on Graves’ disease, in which he introduced the so called Clinical Activity Score. Next, he went to the University Hospital of Utrecht to initiate Holland’s second orbital center. After the Chernobyl disaster, he was sent by his government to Belarus to set up thyroid eye clinics.
Prof Ursula Schmidt-Erfurth
Ursula Schmidt-Erfurth is Professor and Chair of the Department of Ophthalmology at the University Eye Hospital, Vienna, Austria, one of the largest academic institutions in ophthalmology in Europe. Professor Schmidt-Erfurth’s clinical activities include surgical and medical retina. Her scientific research focuses on the development of novel diagnostic techniques, e.g., retinal imaging and novel treatment strategies such as intravitreal pharmacotherapy. She has founded the Vienna Study Center (VSC), which serves as the principal site for multi-center clinical trials, and the Vienna Reading Center (VRC), an independent institution for digital imaging performing image analysis for over 140 clinical sites worldwide. She is head of the OPTIMA project, which is a continuation in the development of advanced image analysis (Christian Doppler Laboratory for Ophthalmic Image Analysis).